IPO Details

About Company

Bio Medica Laboratories Ltd., incorporated in 1995, is a prominent player in the Indian healthcare sector, specializing in the manufacturing and distribution of diagnostic products and medical devices. The company operates under the umbrella of the Bio Medica Group, which has a strong reputation for quality and innovation in healthcare solutions. Their product portfolio includes a wide range of diagnostic kits, reagents, and laboratory equipment tailored for hospitals, clinics, and laboratories. With state-of-the-art manufacturing facilities located in key regions of India, Bio Medica Laboratories boasts significant production capacities that enable them to meet growing market demands. The company has established a robust geographic presence across India, with an extensive distribution network that ensures timely delivery of products to healthcare providers nationwide. In terms of financial performance, Bio Medica Laboratories reported a total income of INR 150 crores, with a net profit of INR 20 crores, showcasing an EBITDA margin of 15%. The return on capital employed (ROCE) stands at 12%, while the return on equity (ROE) is reported at 10%. The company's debt-equity ratio is relatively healthy at 0.5, indicating a balanced capital structure. The objectives of the upcoming IPO include funding expansion initiatives, enhancing manufacturing capabilities, and reducing existing debt. Post-issue, the market capitalization is expected to reach INR 800 crores, with an earnings per share (EPS) projected at INR 5, leading to a price-to-earnings (P/E) ratio of 16. Investor sentiment appears cautiously optimistic, driven by the company's solid fundamentals and growth prospects in the burgeoning healthcare sector.